Jin Medical International (ZJYL) Notes Payables (2023 - 2025)

Jin Medical International (ZJYL) has reported Notes Payables for 3 consecutive years, with $18.8 million the latest figure, recorded in Q3 2025.

• Quarterly Notes Payables rose 66.37% year-over-year to $18.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18.8 million (up 66.37% YoY) and the FY2025 annual result came in at $18.8 million, up 66.37% from the prior year.
• Notes Payables rose to $18.8 million in Q3 2025 per ZJYL's latest filing, from $15.7 million in the prior quarter.
• Over the last five years, Notes Payables for ZJYL reached as high as $18.8 million in Q3 2025 and fell as low as $1.5 million in Q1 2023.
• A 3-year average of $10.2 million and a median of $10.5 million in 2024 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2024 — Notes Payables soared 564.91% — and 2025, when it soared 62.45%.
• Year by year, Notes Payables stood at $4.1 million in 2023, then jumped by 175.28% to $11.3 million in 2024, then soared by 66.37% to $18.8 million in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $18.8 million, $15.7 million, and $11.3 million for Q3 2025, Q1 2025, and Q3 2024 respectively.